Cleveland Medical Devices Inc.

Cleveland Medical Devices Inc, commonly known as CleveMed, is a privately held medical device company headquartered in Cleveland, Ohio, U.S., founded in 1990. As of March 2026, the company had approximately 37 employees and an estimated annual revenue of $13.6 million, placing it in the $5M-$20M revenue band for medical device companies in Ohio. In April 2025, CleveMed was acquired by Beacon Biosignals and now operates as an indirect subsidiary.

CleveMed specializes in designing, developing, manufacturing, and marketing biomedical signal processing and instrumentation devices, with a primary focus on portable systems for sleep disorder testing. Their product lines include home sleep monitors like SleepView, the SleepView Web Portal for physicians to access real-time patient data, and SleepViewSM Direct for home fulfillment services. They also offer accessories such as the ID Check chain-of-custody sensor for home sleep studies.

In terms of patent litigation, Cleveland Medical Devices Inc has been exclusively a defendant in two tracked cases, both brought by Unified Patents before the Patent Trial and Appeal Board (PTAB). This posture indicates that CleveMed is an operating company whose patents are being challenged, rather than an entity primarily engaged in patent assertion. Unified Patents is a membership organization that actively challenges patents, often via Inter Partes Reviews, to deter non-practicing entity (NPE) assertions and improve patent quality.

The two notable cases, both styled "Unified Patents v. Cleveland Medical Devices Inc," reflect Unified Patents' strategy of challenging existing patents held by operating companies, likely to invalidate patents perceived as low quality or to prevent their assertion. The proceedings at the PTAB suggest that the validity of CleveMed's patents is being reviewed.